The biggest difference between the groups was in the increase in hBD3 levels; 7.32-fold (p = 0.004) in BC AB0 group, 7.63-fold (p = 0.004) in BC AB6, and 1.15-fold (p = 0.3), 1.71-fold (p = 0.03), 17.38-fold (p = 0.001) in FQ, FOS, and BL groups, respectively (Figure 7B). Here, FOS is linked to breast cancer.